Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,542,980
  • Shares Outstanding, K 171,949
  • Annual Sales, $ 1,491 M
  • Annual Income, $ -848,530 K
  • 60-Month Beta 1.38
  • Price/Sales 12.90
  • Price/Cash Flow 70.93
  • Price/Book 5.41
Trade EXAS with:

Options Overview

Details
  • Implied Volatility 44.76%
  • Historical Volatility 38.52%
  • IV Percentile 4%
  • IV Rank 15.22%
  • IV High 69.10% on 03/05/21
  • IV Low 40.39% on 08/25/20
  • Put/Call Vol Ratio 1.70
  • Today's Volume 928
  • Volume Avg (30-Day) 1,981
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 66,220
  • Open Int (30-Day) 64,157

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.89
  • Number of Estimates 6
  • High Estimate -0.67
  • Low Estimate -1.15
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -147.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
101.41 +6.52%
on 08/03/21
122.99 -12.17%
on 07/07/21
-14.80 (-12.05%)
since 07/02/21
3-Month
89.90 +20.16%
on 05/13/21
133.99 -19.38%
on 06/28/21
-2.63 (-2.38%)
since 05/05/21
52-Week
70.75 +52.68%
on 09/22/20
159.54 -32.29%
on 01/25/21
+16.08 (+17.49%)
since 08/05/20

Most Recent Stories

More News
Bear of the Day: NeoGenomics (NEO)

Emerging diagnostics provider is steadily growing sales and key M&A but ran into an EPS cliff

NEO : 47.71 (+0.46%)
EXAS : 108.02 (+2.07%)
NVTA : 30.87 (-0.16%)
NTRA : 119.64 (+4.47%)
GH : 115.39 (+1.35%)
Exact Sciences (EXAS) Q2 Loss Wider Than Expected, Revenues Top

Exact Sciences' (EXAS) legacy Screening business sees significant improvement in revenues during the second quarter on Cologuard volume growth.

AMN : 106.47 (+5.24%)
GMED : 79.90 (-0.91%)
EXAS : 108.02 (+2.07%)
CTLT : 122.12 (-0.63%)
Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of -43.06% and 3.84%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

EXAS : 108.02 (+2.07%)
Exact Sciences: Q2 Earnings Snapshot

MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Wednesday reported a loss of $176.9 million in its second quarter.

EXAS : 108.02 (+2.07%)
Exact Sciences Announces Second Quarter 2021 Results

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of for the second quarter ended June 30, 2021, compared to for the same period of 2020.

EXAS : 108.02 (+2.07%)
Stanley Lapidus, Founder and Former Chairman & CEO of Exact Sciences, Joins PAVmed Subsidiary Lucid Diagnostics as Vice Chairman of its Board of Directors

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that medical diagnostics pioneer Stanley...

PAVM : 7.61 (+8.87%)
PAVMZ : 5.85 (+9.04%)
EXAS : 108.02 (+2.07%)
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.

IRWD : 13.29 (+2.70%)
ABBV : 115.12 (+0.03%)
EXAS : 108.02 (+2.07%)
TLRY : 14.47 (+3.65%)
Albireo (ALBO) Gets FDA Nod for Rare Liver Disease Drug

Following FDA approval, Albireo's (ALBO) Bylvay becomes the first drug to treat pruritus in PFIC.

BMRN : 77.93 (+1.95%)
EXAS : 108.02 (+2.07%)
ALBO : 30.02 (+9.01%)
TVTX : 14.63 (+2.96%)
Exact Sciences, Vericel Corp, Home Depot, ExxonMobil and Discover Financial Services highlighted as Zacks Bull and Bear of the Day

Exact Sciences, Vericel Corp, Home Depot, ExxonMobil and Discover Financial Services highlighted as Zacks Bull and Bear of the Day

DFS : 127.10 (+0.78%)
XOM : 57.20 (+0.63%)
HD : 333.11 (+0.85%)
EXAS : 108.02 (+2.07%)
VCEL : 50.61 (+2.91%)
Bull of the Day: Exact Sciences (EXAS)

EPS surprises abound as Cologuard and Precision Oncology grow sales 20% into next year

EXAS : 108.02 (+2.07%)
ADPT : 37.69 (+0.88%)
NVTA : 30.87 (-0.16%)
NTRA : 119.64 (+4.47%)
GH : 115.39 (+1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Key Turning Points

3rd Resistance Point 113.29
2nd Resistance Point 110.67
1st Resistance Point 109.34
Last Price 108.02
1st Support Level 105.39
2nd Support Level 102.77
3rd Support Level 101.44

See More

52-Week High 159.54
Fibonacci 61.8% 125.62
Fibonacci 50% 115.14
Last Price 108.02
Fibonacci 38.2% 104.67
52-Week Low 70.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar